As previous results already show that the stability of Akt in mice MEF cells [16] and mice leukemia cells [18] is maintained by the TM phosphorylation and HSP90, we ask what would happen to Akt levels of myeloma cells if we inhibit both mTOR2 and Hsp90. Here, AKT1 is linked to plasma cell myeloma.